http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0339632-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
| filingDate | 1989-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_622995c491c37cd0455ee7ebabd6b1da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c77936fce552d2606835f91c46d9f71 |
| publicationDate | 1989-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0339632-A2 |
| titleOfInvention | Method of assaying human cancer antigens |
| abstract | A method of determining the human cancer antigen level in a serum sample by sandwich-technique enzyme immunoassay which comprises using, as the first antibody, a mixture of anti-human pulmonary adenocarcinoma monoclonal antibody ALC-186 and anti-human gastric cancer monoclonal antibody AMC-462 or a mixture of anti-human pulmonary adenocarcinoma monoclonal antibody ALC-186 and anti-human pulmonary squamous cell carcinoma monoclonal antibody SLC-454, immobilizing said first antibody on a solid phase, allowing a human serum sample to contact with said first antibody for causing a cancer antigen or antigens in the serum to be bound to said first antibody, then allowing a mixture of peroxidase-labeled anti-human pulmonary adenocarcinoma monoclonal antibody ALC-186 and β-galactosidase-labeled anti-human gastric cancer monoclonal antibody AMC-462, when the first antibody is a mixture of anti-human pulmonary adenocarcinoma monoclonal antibody ALC-186 and anti-human gastric cancer monoclonal antibody AMC-462, or a mixture of peroxidase-labeled anti-human pulmonary adenocarcinoma monoclonal antibody ALC-186 and β-galactosidase-labeled anti-human pulmonary squamous cell carcinoma monoclonal antibody SLC-454, when the first antibody is a mixture of anti-human pulmonary adenocarcinoma monoclonal antibody ALC-186 and anti-human pulmonary squamous cell carcinoma SLC-454, which is used each as the second antibody, to be bound to said cancer antigen or antigens, assaying the thus-bound β-galactosidase-labeled second antibody by addition of a substrate for β-galactosidase followed by enzyme activity measurement, and then assaying the bound peroxidase-labeled second antibody by addition of a substrate for peroxidase followed by enzyme activity measurement. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0402757-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0402757-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0484863-A1 |
| priorityDate | 1988-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 184.